查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386577

诱导诱导性多功能干细胞市场报告：2030 年趋势、预测与竞争分析

Induced Pluripotent Stem Cell Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

诱导性多功能干细胞的趋势和预测

预计到 2030 年，全球诱导性多功能干细胞市场将达到约 26 亿美元，2024 年至 2030 年复合年增长率为 10.3%。市场的主要驱动力是癌症发生率上升、干细胞研究财政投资不断增加，以及诱导诱导性多功能干细胞干细胞（ESC）的众多优势。全球诱导性多功能干细胞市场的未来前景广阔，研究和学术机构、生物技术和製药公司以及医院和诊所市场存在商机。

诱导性多功能干细胞市场洞察

Lucintel 预测，由于慢性病在世界各地普遍存在，药物开发和发现仍将是预测期内最大的部分。

由于对基于干细胞的研究的强劲且具有成本效益的关注、经济的扩张、医疗保健策略的改进以及对个体化治疗前景的认识不断增强，预计亚太地区将在预测期内经历最快的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2. 哪个产业将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球诱导性多功能干细胞市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球诱导性多功能干细胞市场趋势（2018-2023）与预测（2024-2030）
  • 按工作流程分類的全球诱导性多功能干细胞市场
    • 重新程式设计
    • 细胞培养
    • 细胞表征/分析
    • 工程
    • 其他的
  • 全球诱导性多功能干细胞市场（按应用）
    • 药物研发发现和发现
    • 再生医学
    • 毒理学研究
    • 其他的
  • 以最终用途分類的全球诱导性多功能干细胞市场
    • 研究/学术机构
    • 生技/製药公司
    • 医院/诊所

第四章 2018-2030年区域市场趋势及预测分析

  • 全球诱导性多功能干细胞市场按地区划分
  • 诱导性多功能干细胞市场
  • 欧洲诱导性多功能干细胞市场
  • 亚太诱导性多功能干细胞市场
  • 其他地区的诱导性多功能干细胞市场

第五章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按工作流程分類的全球诱导性多功能干细胞市场成长机会
    • 全球诱导性多功能干细胞市场成长机会（按应用）
    • 全球诱导性多功能干细胞市场成长机会（依最终用途）
    • 全球诱导性多功能干细胞市场成长机会（按地区）
  • 全球诱导性多功能干细胞市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球诱导性多功能干细胞市场的产能扩张
    • 全球诱导性多功能干细胞市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • Lonza
  • Axol Bioscience
  • Evotec
  • Hitachi
  • REPROCELL
  • Merck
  • REPROCELLS
  • Fate Therapeutics
  • Thermo Fisher Scientific
  • StemCellsFactory III
简介目录

Induced Pluripotent Stem Cell Trends and Forecast

The future of the global induced pluripotent stem cell market looks promising with opportunities in the research & academic institute, biotechnology & pharmaceutical company, and hospital & clinic markets. The global induced pluripotent stem cell market is expected to reach an estimated $2.6 billion by 2030 with a CAGR of 10.3% from 2024 to 2030. The major drivers for this market are rising prevalence of cancer, amplified financial investments in stem cell research, and the numerous benefits of induced pluripotent stem cells (iPSCs) compared to embryonic stem cells (ESCs).

A more than 150-page report is developed to help in your business decisions.

Induced Pluripotent Stem Cell by Segment

The study includes a forecast for the global induced pluripotent stem cell by workflow, application, end use, and region.

Induced Pluripotent Stem Cell Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:

  • Reprogramming
  • Cell Culture
  • Cell Characterization / Analysis
  • Engineering
  • Others

Induced Pluripotent Stem Cell Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Drug Development & Discovery
  • Regenerative Medicine
  • Toxicology Studies
  • Others

Induced Pluripotent Stem Cell Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Research & Academic Institutes
  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Clinics

Induced Pluripotent Stem Cell Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Induced Pluripotent Stem Cell Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies induced pluripotent stem cell companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the induced pluripotent stem cell companies profiled in this report include-

  • Lonza
  • Axol Bioscience
  • Evotec
  • Hitachi
  • Reprocell
  • Merck
  • Reprocells
  • Fate Therapeutics
  • Thermo Fisher Scientific
  • Stemcellsfactory III

Induced Pluripotent Stem Cell Market Insights

Lucintel forecasts that drug development & discovery will remain the largest segment over the forecast period because the chronic illnesses are spreading throughout the world.

APAC is expected to witness fastest growth over the forecast period due to robust, cost-effective focus on stem cell-based research, the expansion of economies, improvements in healthcare strategies, and the increasing recognition of the promise of personalized treatments.

Features of the Global Induced Pluripotent Stem Cell Market

Market Size Estimates: Induced pluripotent stem cell market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Induced pluripotent stem cell market size by workflow, application, end use, and region in terms of value ($B).

Regional Analysis: Induced pluripotent stem cell market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different workflow, application, end use, and regions for the induced pluripotent stem cell market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the induced pluripotent stem cell market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the induced pluripotent stem cell market size?

Answer: The global induced pluripotent stem cell market is expected to reach an estimated $2.6 billion by 2030.

Q.2 What is the growth forecast for induced pluripotent stem cell market?

Answer: The global induced pluripotent stem cell market is expected to grow with a CAGR of 10.3% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the induced pluripotent stem cell market?

Answer: The major drivers for this market are rising prevalence of cancer, amplified financial investments in stem cell research, and the numerous benefits of induced pluripotent stem cells (iPSCs) compared to embryonic stem cells (ESCs).

Q4. What are the major segments for induced pluripotent stem cell market?

Answer: The future of the global induced pluripotent stem cell market looks promising with opportunities in the research & academic institute, biotechnology & pharmaceutical company, and hospital & clinic markets.

Q5. Who are the key induced pluripotent stem cell market companies?

Answer: Some of the key induced pluripotent stem cell companies are as follows:

  • Lonza
  • Axol Bioscience
  • Evotec
  • Hitachi
  • Reprocell
  • Merck
  • Reprocells
  • Fate Therapeutics
  • Thermo Fisher Scientific
  • Stemcellsfactory III

Q6. Which induced pluripotent stem cell market segment will be the largest in future?

Answer: Lucintel forecasts that drug development & discovery will remain the largest segment over the forecast period because the chronic illnesses are spreading throughout the world.

Q7. In induced pluripotent stem cell market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness fastest growth over the forecast period due to robust, cost-effective focus on stem cell-based research, the expansion of economies, improvements in healthcare strategies, and the increasing recognition of the promise of personalized treatments.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the induced pluripotent stem cell market by workflow (reprogramming, cell culture, cell characterization / analysis, engineering, and others), application (drug development & discovery, regenerative medicine, toxicology studies, and others), end use (research & academic institutes, biotechnology & pharmaceutical companies, and hospitals & clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Induced Pluripotent Stem Cell Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Induced Pluripotent Stem Cell Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Induced Pluripotent Stem Cell Market by Workflow
    • 3.3.1: Reprogramming
    • 3.3.2: Cell Culture
    • 3.3.3: Cell Characterization / Analysis
    • 3.3.4: Engineering
    • 3.3.5: Others
  • 3.4: Global Induced Pluripotent Stem Cell Market by Application
    • 3.4.1: Drug Development & Discovery
    • 3.4.2: Regenerative Medicine
    • 3.4.3: Toxicology Studies
    • 3.4.4: Others
  • 3.5: Global Induced Pluripotent Stem Cell Market by End Use
    • 3.5.1: Research & Academic Institutes
    • 3.5.2: Biotechnology & Pharmaceutical Companies
    • 3.5.3: Hospitals & Clinics

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Induced Pluripotent Stem Cell Market by Region
  • 4.2: North American Induced Pluripotent Stem Cell Market
    • 4.2.1: North American Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
    • 4.2.2: North American Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics
  • 4.3: European Induced Pluripotent Stem Cell Market
    • 4.3.1: European Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
    • 4.3.2: European Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics
  • 4.4: APAC Induced Pluripotent Stem Cell Market
    • 4.4.1: APAC Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
    • 4.4.2: APAC Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics
  • 4.5: ROW Induced Pluripotent Stem Cell Market
    • 4.5.1: ROW Induced Pluripotent Stem Cell Market by Application: Drug Development & Discovery, Regenerative Medicine, Toxicology Studies, and Others
    • 4.5.2: ROW Induced Pluripotent Stem Cell Market by End Use: Research & Academic Institutes, Biotechnology & Pharmaceutical Companies, and Hospitals & Clinics

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Workflow
    • 6.1.2: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Application
    • 6.1.3: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by End Use
    • 6.1.4: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Region
  • 6.2: Emerging Trends in the Global Induced Pluripotent Stem Cell Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Induced Pluripotent Stem Cell Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Induced Pluripotent Stem Cell Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Lonza
  • 7.2: Axol Bioscience
  • 7.3: Evotec
  • 7.4: Hitachi
  • 7.5: REPROCELL
  • 7.6: Merck
  • 7.7: REPROCELLS
  • 7.8: Fate Therapeutics
  • 7.9: Thermo Fisher Scientific
  • 7.10: StemCellsFactory III